Burn Mouth Syndrome
Conditions
Interventions
This is a two-arm, single-blind, randomized controlled clinical trial. The expected sample size is 35 participants in each group, who will be allocated through a computer-generated random sequence. Ex
E02.190.755
Sponsors
Hospital de Clínicas da Universidade Federal do Paraná
Universidade Federal do Paraná
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age; both genders; previous diagnosis of Burning Mouth Syndrome; diagnosed during the study
Exclusion criteria
Exclusion criteria: history of Liver Disease; using Anticoagulants; family history of Schizophrenia; symptoms associated with other comorbidities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A substantial decrease in the burning mouth sensation is expected during the medication use period, as measured by the visual analog scale for pain intensity, based on the observation of at least a 50% variation between pre- and post-intervention assessments. | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in patients' quality of life is expected during the medication use period, as assessed by the OHIP-14 questionnaire, based on the observation of at least a 50% variation between pre- and post-intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactGuilherme Klein Parise
Universidade Federal do Paraná
Outcome results
None listed